ANCO’s ASCO Highlights 2019
2019 ANCO's ASCO Update on Metastatic NSCLC: New Strategies of EGFR Therapy Addressing Combination Approaches, Sequencing, and 3rd Gen TKI Resistance
By
ANCO’s ASCO Highlights 2019
FEATURING
Jennifer Suga
By
ANCO’s ASCO Highlights 2019
FEATURING
Jennifer Suga
Login to view comments.
Click here to Login
